Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a paper released today in the publication Stroke, Professor Kazem Rahimi of the George Institute for Global Health, Nuffield Department of Obstetrics and Gynaecology, describes research findings that show heightened blood pressure increases the risk of developing vascular dementia by 62%.

High blood pressure could significantly raise the risk of developing the second most common form of dementia, according to a new study from The George Institute for Global Health.

The medical records of more than four million people were analysed with researchers finding heightened blood pressure was associated with a 62 per cent higher risk of vascular dementia between the ages of 30-50.

Lead author Professor Kazem Rahimi, of The George Institute for Global Health, said: “Vascular dementia rates are increasing all over the world and will pose a significant economic and social burden in both developed and developing countries. So these results are particularly important.

“We already know that high blood pressure can raise the risk of stroke and heart attack. Our research has shown that high blood pressure is also associated with a significantly higher risk of vascular dementia.”

Key findings:

  • The team at The George Institute analysed the medical records of 4.28 million people in the UK.
  • They found over a seven year period 11,114 people went onto develop vascular dementia.
  • The study found patients aged 30-50, who had high blood pressure, had a 62 per cent higher risk of vascular dementia, and a 26 per cent higher risk at age 51-70.
  • The study also found that high blood pressure was still a risk factor even after adjusting for the presence of stroke, the leading cause of vascular dementia.

Professor Rahimi, deputy director of The George Institute UK, said: “Our results suggest that lowering blood pressure, either by exercise, diet or blood pressure lowering drugs, could reduce the risk of vascular dementia.”

Vascular dementia affects around 9.3 million people globally and is caused by reduced blood supply to the brain due to diseased blood vessels.

High blood pressure cause problems by damaging and narrowing the blood vessels in the brain. Over time, this raises the risk of a blood vessel becoming blocked or bursting. It’s a known risk factor for stroke and cardiovascular disease but until now studies were conflicting over the risks for vascular dementia with several even indicating that low blood pressure was associated with an increased risk of dementia.

Visit the George Institute website for more information.

Similar stories

The link between childhood risk factors and adult cardiovascular events revealed

A new international study published April 4th 2022, in The New England Journal of Medicine finds, for the first time, direct evidence that the recognised risk factors for cardiovascular disease when present in childhood, predict the risk of adult cardiovascular events such as myocardial infarction and stroke.

Global INTERCOVID-2022 Study launched to compare Covid-19 during pregnancy, with pregnant women without the infection.

The Oxford Maternal & Perinatal Health Institute (OMPHI) has launched the 2022 round of the global study to evaluate the effects of Covid-19 variants and vaccination in pregnancy.

Blood pressure drugs could protect against type 2 diabetes

Lowering high blood pressure is an effective way to reduce a person’s risk of developing type 2 diabetes in the future.

Women and older people are most likely to be exposed to shortcomings in heart failure care

A study by Dr Nathalie Conrad and Prof Kazaem Rahimi at the George Institute (Nuffield Department of Women's and Reproductive Health) finds that women and older people are most likely to be exposed to shortcomings in heart failure care.

Skin colour and neurodevelopment are not linked

The latest findings from the international INTERGROWTH-21st Project, that has monitored healthy, urban children from educated families across four continents from early pregnancy to 2 years of age, show that human neurodevelopment is not influenced by the colour of an individual’s skin.